Ceftazidime Panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - Nosocomial pneumonia- Broncho-pulmonary infections in cystic fibrosis- Bacterial meningitis- Chronic supportive otitis media- Malignant otitis externa- Complicated urinary tract infections- Complicated skin and soft issues infections- Complicated intra-abdominal infections- Bone and joint infections- Peritonitis associated with dialysis in patients with CAPDTreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (TURP).